In episode sixteen of "Selling to Healthcare," Lisa T. Miller takes on one of the most persistent myths in modern B2B sales — the idea that executives can no longer make meaningful buying decisions without full committee consensus.
Drawing on behavioral economics, neuroscience, and real-world case studies, Lisa explains what actually drives the final yes and why the brands that win in healthcare aren't the loudest or the most feature-rich, but the most trusted.
https://t.co/IqT1WKNRuM
The conversation you thought was the start of the hospital deal is closer to the middle.
Often the end.
Eighty-one percent of the B2B buying cycle now happens before a buyer ever talks to a salesperson. For hospital sales — already the most layered environment in B2B — that shift has made the pre-sale window denser, longer, and almost entirely self-directed.
Ten stakeholders are now shaping each decision. They aren't coordinating. They're gathering information independently, mostly through content, and arriving at the table with their own conclusions already formed.
Your job between the first signal of interest and the first call is to make sure the version of you that lives in their heads is the version you'd actually want representing the deal.
Most sellers have no idea what that version looks like, because they've never audited it.
In my latest article, I walk through:
~ What 88 touchpoints actually look like inside a hospital decision.
~ Why "build a content engine" is quietly failing across healthcare commercial teams.
~ The AI search audit almost no one has run yet — and why the teams that run it first will own the next several years of pre-sale visibility
Read it here:
https://t.co/JAp0L7paBb